The Texas Healthcare & Bioscience Institute (THBI) works to promote effective legislation and a steady regulatory environment at the state and federal levels. With a focus on using advocacy as a tool to create a more favorable business environment for various healthcare entities, we work with government and industry leaders to attract new participants in the life sciences.
The mission of the Texas Healthcare and Bioscience Institute is to develop and advocate policies and actions that promote biomedical science, biotechnology, agriculture and medical device innovation in Texas.
Our members not only have a voice at the Capitol through our revered legislative team, but they also benefit from extensive networking in the healthcare space across Texas. THBI is the leading health policy voice in the state, influencing legislation that has led to economic investment and medical breakthroughs for over 20 years.
THBI LEADERSHIP
David R. Margrave
Shreekanth Mandayam
Vice Chairman | Texas State University
Holli Hill
Secretary | Novartis Pharmaceuticals
Bradley Westmoreland
Treasurer | Genentech, Inc.
Vertex Pharmaceuticals
Melisa McEwen
AstraZeneca
Mark Moreno
MD Anderson Cancer Center
Zoey Powers
Eli Lilly & Company
Jack Quinn
Rice University
Jeffrey L. Wade
Consultant
Jeffrey Woodhouse
GSK
(open)
Pfizer
THBI STAFF
Victoria Ford, MPA
President & CEO
Miranda Goodsheller
Director of Operations & Economic Development
Alex Harber
Executive Assistant
Danielle Lobsinger Bush
Director of Policy
Julia Perkins
Director of Membership & Programming